PharmaVoice 100: Page 7

  • headshot
    Image attribution tooltip
    Permission granted by Mary Harmon
    Image attribution tooltip
    Q&A

    PTC's vice president of patient relations outlines the importance of patient input in rare disease R&D

    You can't know what matters to rare disease patients unless you ask them.

    By Kim Ribbink • Feb. 3, 2022
  • headshot
    Image attribution tooltip
    Permission granted by Peter Anastasiou
    Image attribution tooltip
    Q&A // First 90 Days

    New Capsida Biotherapeutics CEO Peter Anastasiou aims to bring AAV therapy to reality

    Read what Capsida CEO Peter Anastasiou has planned for his new role. 

    By • Feb. 3, 2022
  • This week's Woman of the Week Andrea McGonigle of Google Cloud, shares lessons in leadership, technology transformation
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip
    Podcast

    Woman of the Week: Google Cloud's Andrea McGonigle

    Andrea McGonigle, Google Cloud’s general manager, healthcare and life sciences partnerships and strategic initiatives, is intent on bringing technology and innovation together to solve some of the biggest challenges in healthcare.

    By • Feb. 2, 2022
  • Three people are having an in-office meeting
    Image attribution tooltip
    Pekic via Getty Images
    Image attribution tooltip
    Opinion

    Talent acquisition stays top of mind for pharma execs

    From creating flexible work environments to looking outside the industry for new talent, pharma execs are shifting strategies to keep their teams afloat.

    By • Feb. 1, 2022
  • Image attribution tooltip
    Retrieved from Rare Disease.org.
    Image attribution tooltip
    Q&A

    For the CEO of Travere, running a rare disease company is personal

    To kick off Rare Disease month, we interview the CEO of Travere Therapeutics

    By Kim Ribbink • Feb. 1, 2022
  • Image attribution tooltip
    The image by Pixabay is licensed under CC BY 1.0
    Image attribution tooltip
    Q&A

    Foghorn's CEO on why collaborations are key to unlocking precision medicine

    With a major development deal under his belt, Adrian Gottschalk is helping the company advance its innovative platform.

    By Robin Robinson • Jan. 28, 2022
  • headshot
    Image attribution tooltip
    Retrieved from Google image.
    Image attribution tooltip
    Profile

    Evofem CEO Saundra Pelletier aims to level the playing field between men's and women's health

    Evofem CEO and PharmaVoice100, Saundra Pelletier, discusses funding challenges for women's health.

    By Alexandra Pecci • Jan. 23, 2022
  • women's health orange and pink
    Image attribution tooltip
    Permission granted by Copyright: <a href='https://www.123rf.com/profile_ileezhun'>ileezhun</a>
    Image attribution tooltip

    Biote CEO breaks down barriers in women's health

    Women’s health is coming into sharper focus in 2022, but getting funding is still difficult.

    By Robin Robinson • Jan. 11, 2022
  • photo of Ovid tweet
    Image attribution tooltip
    [photo]. Retrieved from Ovid Therapeutics.
    Image attribution tooltip
    Q&A

    Ovid's CEO shares his vision for rare disease developments

    Jeremy Levin, chairman and CEO of Ovid Therapeutics discusses the keys to success in rare disease innovation.

    By Kim Ribbink • Jan. 10, 2022
  • Image attribution tooltip
    Justin Sullivan/ via Getty Images
    Image attribution tooltip
    Q&A

    How the executive VP of HR at Incyte is tackling pharma's hiring woes

    In an industry undergoing rapid growth, the increasing job opening rates and limited talent pool are taking on a new level of importance.

    By • Jan. 10, 2022
  • Header image for Red Jacket Awards
    Image attribution tooltip
    Shaun Lucas/PharmaVoice
    Image attribution tooltip
    Red Jacket honorees 2022

    The Red Jacket awards

    The PharmaVoice 100 ‘hall of fame’ winners

    By Megan McCoskey • Dec. 22, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip
    Profile

    PharmaVoice 100 Who's on the List – By Category

    Who’s on the List — 2021 Indexed by Category Commanders & Chiefs Dr. Sam Agresta Foghorn Therapeutics Alisha Alaimo Biogen Shideh Bina Insigniam Dr. Norbert Bischofberger Kronos Bio Dr. James Kyle Bryan IQVIA Biotech Victor Bultó Novartis Pharmaceuticals Dr. Tony ...

    By PharmaVoice Team • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip
    Profile

    Commanders & Chiefs

    These forward-thinking leaders are inspiring their teams to achieve far-reaching goals and strategically positioning their companies for success as they navigate complex industry challenges. Be bold Igniting change by… Addressing barriers between patients and their medicines Vict...

    By PharmaVoice Team • Aug. 1, 2021